Veru’s Covid-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients (biospace.com)

Good stuff. Previous drug that shows both anti-inflammatory and anti-viral activity AND it’s orally available. Hopefully, it’s easy to manufacture and distribute.